Generics and Biosimilars: Ensuring Quality from Beginning to EndBy PerkinElmer
When a new drug is first developed by a pharmaceutical company, it is initially sold under a brand name and the product is covered under patent protection. This means that the only company allowed to manufacture, market, and profit from the drug is the innovator company that holds the patent.
However, once a patent expires, opportunities arise for companies other than the innovator to manufacture and sell the product as a generic or biosimilar medicine.
To read more, please download this free white paper.